HHS Secretary Tom Price, in a letter to Sen. Patty Murray, D-Wash., called on the Senate to restructure and increase the user fee programs for medical devices, pharmaceuticals, generic drugs and biosimilars to enable further cuts to the FDA's appropriations from Congress. Murray said if the proposal is implemented, it would "leave the FDA hamstrung and without the federal investments it relies on to carry out its important public health work."
Price calls for higher user fees, cuts in FDA's appropriations
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.